Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
PERCEPTIVE ADVISORS LLC (CIK 1224962) reported $5.12B across 86 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PRAX ($656.0M, 12.82%), CELC ($356.9M, 6.97%), ASND ($350.3M, 6.84%), ROIV ($229.5M, 4.48%), CNTA ($208.9M, 4.08%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | $656.0M | 12.82% | 2.0M | Added |
| 2 | CELC | CELCUITY INC | $356.9M | 6.97% | 3.1M | Trimmed |
| 3 | ASND | ASCENDIS PHARMA A/S | $350.3M | 6.84% | 1.5M | Added |
| 4 | ROIV | ROIVANT SCIENCES LTD | $229.5M | 4.48% | 8.3M | Added |
| 5 | CNTA | CENTESSA PHARMACEUTICALS PLC | $208.9M | 4.08% | 5.3M | Added |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | $206.4M | 4.03% | 2.4M | Trimmed |
| 7 | SYRE | SPYRE THERAPEUTICS INC | $190.8M | 3.73% | 3.8M | Added |
| 8 | NUVL | NUVALENT INC | $161.9M | 3.16% | 1.6M | Trimmed |
| 9 | EWTX | EDGEWISE THERAPEUTICS INC | $139.4M | 2.72% | 4.4M | Trimmed |
| 10 | PTGX | PROTAGONIST THERAPEUTICS INC | $129.7M | 2.54% | 1.2M | Trimmed |
| 11 | APGE | APOGEE THERAPEUTICS INC | $129.7M | 2.53% | 1.5M | Trimmed |
| 12 | TVTX | TRAVERE THERAPEUTICS INC | $123.1M | 2.40% | 4.1M | Trimmed |
| 13 | AMLX | AMYLYX PHARMACEUTICALS INC | $115.2M | 2.25% | 8.3M | Hold |
| 14 | IMTX | IMMATICS N.V | $102.2M | 2.00% | 10.4M | Hold |
| 15 | INBX | INHIBRX BIOSCIENCES INC | $97.0M | 1.90% | 1.4M | Trimmed |
| 16 | RLAY | RELAY THERAPEUTICS INC | $97.0M | 1.90% | 9.8M | Added |
| 17 | MGTX | MEIRAGTX HLDGS PLC | $89.3M | 1.75% | 10.3M | Hold |
| 18 | ZYME | ZYMEWORKS INC | $87.9M | 1.72% | 3.5M | Added |
| 19 | SLDB | SOLID BIOSCIENCES INC | $85.7M | 1.68% | 11.9M | Added |
| 20 | DYN | DYNE THERAPEUTICS INC | $84.6M | 1.65% | 4.7M | Added |
| 21 | BCRX | BIOCRYST PHARMACEUTICALS INC | $70.8M | 1.38% | 7.4M | Added |
| 22 | ORKA | ORUKA THERAPEUTICS INC | $68.4M | 1.34% | 1.4M | Trimmed |
| 23 | AORT | ARTIVION INC | $60.0M | 1.17% | 1.6M | Trimmed |
| 24 | NRIX | NURIX THERAPEUTICS INC | $57.5M | 1.12% | 3.7M | Added |
| 25 | MRNA | MODERNA INC | $50.8M | 0.99% | 1.0M | New |
Source: SEC Form 13F filings · as of 2026-03-31